Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

Core Insights - Novavax, Inc. will report its third quarter 2025 financial results and operational highlights on November 6, 2025, at 8:30 a.m. ET [1] - The company is focused on tackling global health challenges through its vaccine technology and aims to optimize partnerships and expand its research and development efforts [2] Conference Call Details - The conference call is scheduled for November 6, 2025, at 8:30 a.m. ET, with a registration link provided for participants [1] - Dial-in numbers are available for both U.S. and international participants [1] - A replay of the call will be available starting at 11:30 a.m. ET on November 6, 2025, until November 13, 2025 [2] Company Overview - Novavax specializes in vaccine development, utilizing protein-based nanoparticles and the Matrix-M adjuvant [2] - The company's growth strategy includes optimizing existing partnerships and expanding its technology platform through innovation and collaborations [2]